Stock Events

Stock Events

Universal Ibogaine 

$0.000100
13
-$0.00-50%Friday 18:37

Statistics

Day High
0.008
Day Low
0.008
52W High
0.35
52W Low
0.00001
Volume
9,500
Avg. Volume
179,209
Mkt Cap
30,861
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-88.07%Profit Margin
Unprofitable
2018
2019
2021
2022
2023
2024
1.69MRevenue
-1.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IBOGF. It's not an investment recommendation.
Realty Income
2
O
Schwab US Dividend Equity
2
SCHD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.65B
Compass Pathways focuses on psilocybin therapy for mental health issues, which overlaps with Universal Ibogaine's focus on psychedelic therapies.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences works on developing treatments using psychedelics, targeting the same innovative treatment sector as Universal Ibogaine.
GH Research
GHRS
Mkt Cap1.57B
GH Research is involved in the development of therapeutic solutions using psychedelics, similar to Universal Ibogaine's approach.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, competing in the same industry as Universal Ibogaine.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics works on developing psychedelic medicines, aligning closely with Universal Ibogaine's market.
Noveris Health Sciences
MYCOF
Mkt Cap42.74M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, similar to Universal Ibogaine's objectives.

About

Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Canada.
Show More
CEO
Nicholas Peter Karos
Employees
7
Country
Canada
ISIN
CA91360F1099
WKN
000A3DD3A

Listings

MU
DE
JC4.MU
V
CA
IBO.V
OTC Link
US
IBOGF
F
DE
JC4.F

0 Comments

Share your thoughts

FAQs

What is Universal Ibogaine stock price today?▼
The current price of IBOGF is $0.00 USD — it has decreased by -50% in the past 24 hours. Watch Universal Ibogaine stock price performance more closely on the chart.
What is Universal Ibogaine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Universal Ibogaine stocks are traded under the ticker IBOGF.
Is Universal Ibogaine stock price growing?▼
IBOGF stock has risen by +0% compared to the previous week, the month change is a -50% fall, over the last year Universal Ibogaine has showed a -98.18% decrease.
What is Universal Ibogaine market cap?▼
Today Universal Ibogaine has the market capitalization of 30,861
What is Universal Ibogaine revenue for the last year?▼
Universal Ibogaine revenue for the last year amounts to 1.69M USD.
What is Universal Ibogaine net income for the last year?▼
IBOGF net income for the last year is -1.49M USD.
How many employees does Universal Ibogaine have?▼
As of November 1, 2026, the company has 7 employees.
In which sector is Universal Ibogaine located?▼
Universal Ibogaine operates in the Health & Wellness sector.
When did Universal Ibogaine complete a stock split?▼
Universal Ibogaine has not had any recent stock splits.
Where is Universal Ibogaine headquartered?▼
Universal Ibogaine is headquartered in Calgary, Canada.